Oculus will soon require all of its virtual reality headset users to sign up with a Facebook account. The Facebook-owned company says it will start removing support for separate Oculus accounts in October, although users can maintain an existing account until January 1st, 2023. All users can maintain a distinct “VR profile” with a separate friends list.
Starting later this year, you’ll only be able to sign up for an Oculus account through Facebook. If you already have an account, you’ll be prompted to permanently merge your account. If you don’t, you’ll be able to use the headset normally until 2023, at which point official support will end. Old headsets using non-linked accounts will still work, but some games and apps may no longer function. Developers can keep using an unlinked developer account without social functionality, and the Oculus for Business platform uses a separate login process that will remain unchanged.
Facebook also says that all future unreleased Oculus devices will require a Facebook login, even if you’ve got a separate account already. The company is widely expected to announce a new version of its Oculus Quest headset this fall, and that policy would likely apply to it.
The new changes apparently consolidate Facebook’s management of its platforms. A new privacy policy will be administered by Facebook itself, not the separate Facebook Technologies hardware subsidiary, and “Facebook will manage all decisions around use, processing, retention and sharing of your data.” Oculus will also adopt Facebook’s core community standards rather than use a separate code of conduct, and Facebook will add a new “VR-focused” section to its standards. A single login also slightly simplifies launching experiences like Horizon, the social VR world that Facebook announced last year.
Facebook has been slowly integrating Oculus’ platform after buying the company in 2014. In late 2019, it added new VR social features requiring a Facebook account and began using data gathered through Oculus in ads. The divisions shared information well before that, a fact that has concerned critics of Facebook data collection practices.
In 2018, Facebook confirmed that it could do things like ban linked spam accounts across the platforms, but it has denied invasive tracking of users’ behavior. And while Facebook’s targeted advertising has drawn criticism, it’s not rolling out any new ads on the Oculus platform right now. This new policy removes a final layer of separation between Oculus and Facebook accounts, though, and it forces anyone who’s not on the core Facebook service to finally sign up.
Read the original article on theverge
Biotechnology bio source is a broad area of biology, which involves the use of systems and living organisms to develop or create the product. Depending on the tools and applications, often overlap with related scientific fields.
DeleteA recent report that 93 per cent of invasive cervical cancers worldwide contain human papillomavirus (HPV) may be an underestimate, due to sample usabio inadequacy or integration events affecting the HPV L1 gene, which is the target of the polymerase chain reaction (PCR)-based test which was used. The formerly HPV-negative cases from this study have therefore been reanalyzed for usabio HPV serum antibodies and HPV DNA. Serology for HPV 16 VLPs, E6, and E7 antibodies was performed on 49 of the 66 cases which were HPV-negative and a sample of 48 of the 866 cases which were HPV-positive in the original study. Moreover, 55 of the 66 formerly HPV-negative biopsies were also reanalyzed by a sandwich procedure in which the outer sections in a series of sections are used for histological review, while the inner sections are assayed by three different HPV PCR assays targeting different open reading frames (ORFs). No significant difference usabio was found in serology for HPV 16 proteins between the cases that were usabio originally HPV PCR-negative and -positive. Type-specific E7 PCR for 14 high-risk HPV types detected HPV DNA in 38 (69 per cent) of the 55 originally HPV-negative and amplifiable specimens. The HPV types detected were 16, 18, 31, 33, 39, 45, 52, and 58. Two (4 per cent) additional cases were only HPV DNA-positive by E1 and/or L1 consensus PCR. Histological analysis of the 55 specimens revealed that 21 were qualitatively inadequate. Only two of the 34 adequate samples were HPV-negative on all PCR tests, as against 13 of the 21 that usabio were usabio inadequate ( p< 0.001). Combining the data from this and the previous study and excluding inadequate specimens, the worldwide HPV prevalence in cervical carcinomas is 99.7 per cent. The presence of HPV in virtually all cervical usabio cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer. The extreme rarity of HPV-negative cancers reinforces the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.
Delete